We measured IgG, IgM, and IgG subtype (IgG1, IgG2, IgG3, IgG4) responses to S-RBD in plasma samples from six COVID-19 patients at several time points post-symptoms in separate assays (Fig 5). This evidence concerns the gene IGHG3 and COVID-19.